Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley +1 more source
Peptide-modified phase-transition nanoparticles co-deliver FTO siRNA and Ce6 for sonodynamic metabolism-immunotherapy of melanoma. [PDF]
Li X +15 more
europepmc +1 more source
Long‐Term Trends in Juvenile Blue Crab Recruitment Patterns in a Wind‐Driven Estuary
ABSTRACT Conserving exploited marine species requires understanding population dynamics across life stages and habitats. This study analyzes juvenile blue crab (Callinectes sapidus) recruitment trends in North Carolina's Albemarle‐Pamlico Estuarine System.
Erin Voigt +2 more
wiley +1 more source
Correction: Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs. [PDF]
Zhao J +12 more
europepmc +1 more source
A protective cGAMP-mediated anti-tumor immune response can proceed without LRRC8/VRAC channels. [PDF]
Thöne FMB +4 more
europepmc +1 more source
Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang +7 more
wiley +1 more source
mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy. [PDF]
Gschwendtner A +9 more
europepmc +1 more source
Cytotoxicity of the coagulant Moringa oleifera lectin (cMoL) to B16-F10 melanoma cells.
Luciana de Andrade Luz +5 more
semanticscholar +1 more source

